TrialThe Journal of clinical endocrinology and metabolism2011

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

Anne L Schafer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.